| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4de36eaaa471d491a1c3f2ae25eaef97 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2236-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23F3-166
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-74
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23F3-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23F3-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-192 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-74
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23F3-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-192
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23F3-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23F3-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-10 |
| filingDate |
2020-03-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ff0e8f4bbb946edfa052968eb4d04306
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2e9d4b598b058f58fadf279ff9533834
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f15da1130e02299055502f8a0234b978
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ea3687c70ab15baecc756817aa2c6c53
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cd5b00ea58e28e82f0cc52024d1bc4ee
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_27015af975ece61b80a245f6bffdc99b |
| publicationDate |
2022-06-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2022175864-A1 |
| titleOfInvention |
Use of green coffee based compositions for improving insulin profile |
| abstract |
The present invention relates to a green coffee-based composition comprising hydrolysed chlorogenic acid for use in the treatment or prevention of a disorder linked to an increase in plasma postprandial insulin in a subject. The invention relates also to the non-therapeutic use of a composition comprising an esterase treated decaffeinated green coffee extract with an amount of 40-200 mg administered to a subject per day to decrease plasma postprandial insulin concentration. A further aspect of the invention is a process for forming green coffee based compositions. |
| priorityDate |
2019-03-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |